Support services for studies of infection, immunity, and cancer

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201700006C
Awardee
Awarding agency
Obligated
$13,360,721

Award facts

Opportunity
Contract value 80% obligated
  • $15,124,782.59 Current, with exercised options
  • $16,784,848.00 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Rockville, MD 20850, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00019 · FY26 UDO initiative - support services for studies of infection, immunity, and cancer -$8,301
Funding Only Action P00018 -$2,287
Funding Only Action P00017 -$38,541
Funding Only Action P00016 -$12
Funding Only Action P00015 -$1,452
Funding Only Action P00014 · IPP; support services for studies of infection, immunity, and cancer edited by levyrf_NIH on 02/11/2022 12:12:11 $926,304
Funding Only Action P00013 $937,294
Exercise an Option P00012 $1,220,998
Funding Only Action P00011 -$491,028
Funding Only Action P00010 $491,028
Exercise an Option P00009 $1,982,042
Exercise an Option P00008 $300,000
Funding Only Action P00007 $873,538
Exercise an Option P00006 $1,712,120
Funding Only Action 5 $837,919
Exercise an Option 4 $1,728,723
Funding Only Action 3 $11,700
Funding Only Action 2 $524,400
Funding Only Action 1 $2,156,276
Original award $200,000
Show all 20

About this award

Written by GovTribe AI ·

The National Cancer Institute awarded a definitive contract to Westat, Inc. for support services for studies of infection, immunity, and cancer on March 20, 2017, with a ceiling value of $16.784 million under a cost-plus-fixed-fee structure and no set-aside.

Place of performance is Rockville, MD. The contract supports the FY26 UDO Initiative, delivering research support services centered on federal health research infrastructure. Period of performance runs through March 29, 2022.

Service Contract Inventory reporting captures actual government-invoiced labor on this award: FY2021 invoicing reached $2 million across 4.7 FTEs and 9,684 contractor hours, yielding a derived government-paid hourly rate of $203.90/hr. No subcontractors were reported; Westat self-performed all invoiced work. FY2018 invoicing was $2.2 million and FY2020 invoicing was $2.7 million, reflecting variable staffing across contract cycles.

Quick answers

Who was awarded contract HHSN261201700006C?

HHSN261201700006C was awarded to Westat, Inc. by National Cancer Institute (National Institutes of Health) on March 20, 2017.

How much is contract HHSN261201700006C worth?

The government has obligated $13,360,721 on HHSN261201700006C. Its current value, with exercised options, is $15,124,783. Its potential value, with all options, is $16,784,848.

Was contract HHSN261201700006C competed?

The extent of competition for HHSN261201700006C was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login